AIM
VRTX icon

Aigen Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Aigen Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
7,452
+3,214
+76% +$1.42M 1.01% 12
2026
Q1 		$1.89M Buy
4,238
+3,344
+374% +$1.56M 0.49% 55
2025
Q4 		$405K Buy
+894
New +$385K 0.09% 283
2024
Q3 		– Sell
-1,274
Closed -$597K – 1042
2024
Q2 		$597K Buy
+1,274
New +$553K 0.12% 254
2023
Q3 		– Sell
-4,358
Closed -$1.53M – 1105
2023
Q2 		$1.53M Buy
+4,358
New +$1.47M 0.23% 127
2022
Q4 		– Sell
-6,692
Closed -$1.94M – 794
2022
Q3 		$1.94M Buy
6,692
+5,436
+433% +$1.56M 0.28% 109
2022
Q2 		$354K Buy
+1,256
New +$336K 0.06% 364
2022
Q1 		– Sell
-4,059
Closed -$867K – 1123
2021
Q4 		$867K Sell
4,059
-5,465
-57% -$1.06M 0.05% 463
2021
Q3 		$1.73M Sell
9,524
-20,607
-68% -$4.02M 0.33% 83
2021
Q2 		$6.08M Buy
+30,131
New +$6.3M 1.06% 16
2020
Q4 		– Sell
-20,899
Closed -$5.69M – 1099
2020
Q3 		$5.69M Sell
20,899
-7,804
-27% -$2.15M 0.73% 9
2020
Q2 		$8.33M Buy
28,703
+1,489
+5% +$404K 1.07% 2
2020
Q1 		$6.48M Buy
27,214
+8,037
+42% +$1.84M 0.86% 6
2019
Q4 		$4.2M Buy
+19,177
New +$3.88M 0.7% 15

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Aigen Investment Management's VRTX Position: Q2 2026 in Review

Aigen Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 76% in Q2 2026, buying an estimated $1.42M and bringing the position to 7,452 shares worth $3.7M. The position accounts for 1.01% of the portfolio, ranked #12.

Aigen Investment Management first reported a position in VRTX in Q4 2019 and has held it in 14 quarters since. The position peaked at $8.33M in Q2 2020. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Aigen Investment Management held 7,452 shares of Vertex Pharmaceuticals worth $3.7M as of Q2 2026.
  • Aigen Investment Management bought 3,214 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.42M.
  • Vertex Pharmaceuticals made up 1.01% of Aigen Investment Management's portfolio in Q2 2026, its #12 holding.
  • Aigen Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
  • Aigen Investment Management's Vertex Pharmaceuticals position peaked at $8.33M in Q2 2020.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.